Record US measles cases drive development of new treatments

The US is experiencing its highest number of measles cases in decades, coinciding with declining vaccination rates. Researchers are now developing antiviral drugs to treat those who contract the virus or are especially vulnerable to severe illness. Until now, there have been no approved antivirals for measles, with treatment limited to managing symptoms.